Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease

Anand Kumar Andiappan; Mohammad Asad; Celine Chua; Esha Sehanobish; Zhen Ren; Xue Ying Chan; Josephine Lum; Nicholas Ang; Kaibo Duan; Adam Gersten; Waleed M. Abuzeid; Nadeem Akbar; Marc Gibber; Shanshan Howland; Bernett Lee; Olaf Rotzschke; Steven A. Porcelli; Elina Jerschow

doi:10.1111/all.15198

Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease

Anand Kumar Andiappan, Mohammad Asad, Celine Chua, Esha Sehanobish, Zhen Ren, Xue Ying Chan, Josephine Lum, Nicholas Ang, Kaibo Duan, Adam Gersten, Waleed M. Abuzeid, Nadeem Akbar, Marc Gibber, Shanshan Howland, Bernett Lee, Olaf Rotzschke, Steven A. Porcelli, Elina Jerschow

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	1297-1299
Number of pages	3
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	77
Issue number	4
DOIs	https://doi.org/10.1111/all.15198
State	Published - Apr 2022

Access to Document

10.1111/all.15198

Cite this

Andiappan, A. K., Asad, M., Chua, C., Sehanobish, E., Ren, Z., Chan, X. Y., Lum, J., Ang, N., Duan, K., Gersten, A., Abuzeid, W. M., Akbar, N., Gibber, M., Howland, S., Lee, B., Rotzschke, O., Porcelli, S. A., & Jerschow, E. (2022). Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease. Allergy: European Journal of Allergy and Clinical Immunology, 77(4), 1297-1299. https://doi.org/10.1111/all.15198

@article{121bbf17d4914923a7ab48bbd88c54d4,

title = "Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease",

author = "Andiappan, {Anand Kumar} and Mohammad Asad and Celine Chua and Esha Sehanobish and Zhen Ren and Chan, {Xue Ying} and Josephine Lum and Nicholas Ang and Kaibo Duan and Adam Gersten and Abuzeid, {Waleed M.} and Nadeem Akbar and Marc Gibber and Shanshan Howland and Bernett Lee and Olaf Rotzschke and Porcelli, {Steven A.} and Elina Jerschow",

note = "Funding Information: Portions of this work were supported by the National Institute of Allergy and Infectious Disease R21AI146804 (to EJ), CTSA grant number 5KL2TR001071 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and the Stony Wold‐Herbert Fund research grant (to EJ). Its contents are solely the responsibility of the authors and do not represent the official views of the NIH. A.K. Andiappan was supported by an NMRC (National Medical Research Council), YIRG (Young Individual Research Grant) grant (OFYIRG17nov065), and an Agency for Science, Technology and Research CDA (Career Development Award) grant (202D800012). ",

year = "2022",

month = apr,

doi = "10.1111/all.15198",

language = "English",

volume = "77",

pages = "1297--1299",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

number = "4",

}

Andiappan, AK, Asad, M, Chua, C, Sehanobish, E, Ren, Z, Chan, XY, Lum, J, Ang, N, Duan, K, Gersten, A, Abuzeid, WM, Akbar, N, Gibber, M, Howland, S, Lee, B, Rotzschke, O, Porcelli, SA & Jerschow, E 2022, 'Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease', Allergy: European Journal of Allergy and Clinical Immunology, vol. 77, no. 4, pp. 1297-1299. https://doi.org/10.1111/all.15198

Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease. / Andiappan, Anand Kumar; Asad, Mohammad; Chua, Celine et al.
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, No. 4, 04.2022, p. 1297-1299.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease

AU - Andiappan, Anand Kumar

AU - Asad, Mohammad

AU - Chua, Celine

AU - Sehanobish, Esha

AU - Ren, Zhen

AU - Chan, Xue Ying

AU - Lum, Josephine

AU - Ang, Nicholas

AU - Duan, Kaibo

AU - Gersten, Adam

AU - Abuzeid, Waleed M.

AU - Akbar, Nadeem

AU - Gibber, Marc

AU - Howland, Shanshan

AU - Lee, Bernett

AU - Rotzschke, Olaf

AU - Porcelli, Steven A.

AU - Jerschow, Elina

N1 - Funding Information: Portions of this work were supported by the National Institute of Allergy and Infectious Disease R21AI146804 (to EJ), CTSA grant number 5KL2TR001071 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and the Stony Wold‐Herbert Fund research grant (to EJ). Its contents are solely the responsibility of the authors and do not represent the official views of the NIH. A.K. Andiappan was supported by an NMRC (National Medical Research Council), YIRG (Young Individual Research Grant) grant (OFYIRG17nov065), and an Agency for Science, Technology and Research CDA (Career Development Award) grant (202D800012).

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85121753924&partnerID=8YFLogxK

U2 - 10.1111/all.15198

DO - 10.1111/all.15198

M3 - Letter

C2 - 34921681

AN - SCOPUS:85121753924

SN - 0105-4538

VL - 77

SP - 1297

EP - 1299

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 4

ER -

Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease

Access to Document

Other files and links

Cite this